Aspirin is a powerful anti-platelet drug widely used in patients with coronary atherosclerosis, but its side effects and especially its toxicity for gastrointestinal tract limit its usefulness in specific groups of patients. A new category of agents, nitric oxide-releasing aspirins (such as NCX-4016), seems to provide an alternative solution. Although this drug is still at phase II clinical trials, it has provided promising results until now. When administered in vivo, it is separated into an...Expand abstract
- Publisher copy:
- Copyright date:
Nitric oxide-releasing aspirin: will it say NO to atherothrombosis?
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record